Bone marrow findings in systemic mastocytosis.

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Systemic mastocytosis (SM) is a rare neoplastic proliferation of tissue mast cells with localized and systemic variants.
• Bone marrow involvement is a critical factor in classifying and determining the prognosis of SM.

Purpose of the Study:

• To evaluate cytologic and histologic findings in bone marrow of patients with systemic mastocytosis.
• To distinguish distinct histologic patterns of bone marrow involvement and correlate them with clinical presentation and prognosis.

Main Methods:

• Histologic and cytologic examination of bone marrow samples from 45 patients with systemic mastocytosis.
• Classification of bone marrow involvement into three distinct patterns based on mast cell infiltration and associated changes.

Main Results:

• Three histologic patterns of bone marrow involvement were identified: Type 1 (patchy infiltration, favorable prognosis, associated with skin involvement/urticaria pigmentosa), Type 2 (sheets of mast cells with fibrosis/osteosclerosis, associated with myeloid leukemias, poor prognosis), and Type 3 (diffuse infiltration by atypical mast cells, associated with mast cell leukemia, grave prognosis).
• Type 1 was exclusively seen in patients with primary skin involvement (benign systemic mastocytosis).
• Types 2 and 3 lacked primary skin involvement and were designated malignant systemic mastocytosis, with significantly poorer prognoses.

Conclusions:

• Histologic patterns of bone marrow infiltration in systemic mastocytosis correlate strongly with clinical presentation and patient outcomes.
• Distinguishing between benign and malignant forms of systemic mastocytosis based on bone marrow pathology is crucial for prognosis and management.
• The study highlights the prognostic significance of bone marrow findings in systemic mastocytosis, differentiating between favorable and aggressive disease subtypes.